Bangingi, Abdul A.
HRN: 20-51-12 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2023
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/21/2023
06/28/2023
IV
1.5gms
Q12
Skin Infection (Renal Dose)
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes